Search research articles
Contact Us
Filters
Showing results (111-120 of 288) with videos related to
Page
of 29
Sort By:
Pediatric Cardiology
|
May 19, 2018
Cost-Effectiveness of Ventricular Assist Device Destination Therapy for Advanced Heart Failure in Duchenne Muscular Dystrophy
Defne A Magnetta, JaHyun Kang, Peter D Wearden, et al.
Digestive Diseases and Sciences
|
June 28, 2018
Cost-Effectiveness of Melanoma Screening in Inflammatory Bowel Disease
Alyce J M Anderson, Laura K Ferris, David G Binion, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 29, 2011
The role of CD8(+) T cells in a model of multiple sclerosis induced with recombinant myelin oligodendrocyte glycoprotein
Marija Sajic, Norman Gregson, Christopher Linington, et al.
Journal of Neuroimmunology
|
April 18, 2002
Brain-derived neurotrophic factor in experimental autoimmune neuritis
Paul A Felts, Kenneth J Smith, Norman A Gregson, et al.
Anesthesiology
|
December 2, 2017
Cost-effectiveness Analysis of Intraoperative Cell Salvage for Obstetric Hemorrhage
Grace Lim, Vladyslav Melnyk, Francesca L Facco, et al.
Alcoholism, Clinical and Experimental Research
|
May 12, 2009
Cost-effectiveness of screening for unhealthy alcohol use with % carbohydrate deficient transferrin: results from a literature-based decision analytic computer model
Alok Kapoor, Kevin L Kraemer, Kenneth J Smith, et al.
Annals of Neurology
|
January 31, 2003
Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration
Raju Kapoor, Meirion Davies, Paul A Blaker, et al.
Vaccine
|
September 30, 2009
The timing of influenza vaccination for older adults (65 years and older)
Bruce Y Lee, Julie H Y Tai, Rachel R Bailey, et al.
BMC Pediatrics
|
February 4, 2022
Risk-stratification in febrile infants 29 to 60 days old: a cost-effectiveness analysis
Kathleen A Noorbakhsh, Sriram Ramgopal, Nancy S Rixe, et al.
American Journal of Clinical Oncology
|
October 24, 2019
Cost-Effectiveness Analysis of Upfront SBRT for Oligometastatic Stage IV Non-Small Cell Lung Cancer Based on Mutational Status
Hayeon Kim, John A Vargo, Diane C Ling, et al.
Page
of 29
Search research articles
Search
Showing results (111-120 of 288) with videos related to
Sort By:
Page
of 29
Pediatric Cardiology
|
May 19, 2018
Cost-Effectiveness of Ventricular Assist Device Destination Therapy for Advanced Heart Failure in Duchenne Muscular Dystrophy
Defne A Magnetta, JaHyun Kang, Peter D Wearden, et al.
Digestive Diseases and Sciences
|
June 28, 2018
Cost-Effectiveness of Melanoma Screening in Inflammatory Bowel Disease
Alyce J M Anderson, Laura K Ferris, David G Binion, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 29, 2011
The role of CD8(+) T cells in a model of multiple sclerosis induced with recombinant myelin oligodendrocyte glycoprotein
Marija Sajic, Norman Gregson, Christopher Linington, et al.
Journal of Neuroimmunology
|
April 18, 2002
Brain-derived neurotrophic factor in experimental autoimmune neuritis
Paul A Felts, Kenneth J Smith, Norman A Gregson, et al.
Anesthesiology
|
December 2, 2017
Cost-effectiveness Analysis of Intraoperative Cell Salvage for Obstetric Hemorrhage
Grace Lim, Vladyslav Melnyk, Francesca L Facco, et al.
Alcoholism, Clinical and Experimental Research
|
May 12, 2009
Cost-effectiveness of screening for unhealthy alcohol use with % carbohydrate deficient transferrin: results from a literature-based decision analytic computer model
Alok Kapoor, Kevin L Kraemer, Kenneth J Smith, et al.
Annals of Neurology
|
January 31, 2003
Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration
Raju Kapoor, Meirion Davies, Paul A Blaker, et al.
Vaccine
|
September 30, 2009
The timing of influenza vaccination for older adults (65 years and older)
Bruce Y Lee, Julie H Y Tai, Rachel R Bailey, et al.
BMC Pediatrics
|
February 4, 2022
Risk-stratification in febrile infants 29 to 60 days old: a cost-effectiveness analysis
Kathleen A Noorbakhsh, Sriram Ramgopal, Nancy S Rixe, et al.
American Journal of Clinical Oncology
|
October 24, 2019
Cost-Effectiveness Analysis of Upfront SBRT for Oligometastatic Stage IV Non-Small Cell Lung Cancer Based on Mutational Status
Hayeon Kim, John A Vargo, Diane C Ling, et al.
Page
of 29